This week, the Federal Drug Administration (FDA) acknowledged the usefulness of the drug, Truvada, to safely and effectively reduce the transmission of HIV via sexual intercourse, if taken on a daily basis. The report stated that "the individual at risk may be spared infection with a serious and life-threatening illness that requires lifelong treatment." The drug is currently being used to manage HIV in infected individuals. A panel of experts will review the report later this week to determine whether or not the drug should be approved as a drug to prevent the virus.

More details here.

LYFE Mentors, a new program of the DC Concerned Providers and DC Center, will be hosting three focus groups next week with LGBTQ youth aged 16-24. All participants will receive a $20 gift card for their time and opinions. Each focus group session is one hour.

To sign up for this confidential focus group, please call (202) 543-0094 x21. Respond by Thursday, May 3rd in order to participate.

Dates and times of the confidential focus groups are:

• Monday, May 7th 5-6PM
• Tuesday, May 8th 6-7PM
• Wednesday, May 9th 7-8PM

Learning & Promoting the Female Condom (FC2), a Train-the-Trainer Workshop

Friday, May 4th 
10:00AM-12:00PM
651 Pennsylvania Avenue, SE
Washington, DC 20003
METRO: Eastern Market

Space is limited, please RSVP by clicking here. 

This professional development workshop will explore the history, design and utilization of the female condom (FC2). The workshop will include discussion around how providers can encourage clients to use the FC2 and how the device can supplement the traditional condom for HIV prevention and to prevent unintended pregnancies. This workshop will be a train-the-trainer session.

By the end of this training, participants will be able to:

1. Understand how to use the female condom 
2. Understand the history and purpose of the female condom 
3. Articulate the female condom can prevent HIV, STIs and unintended pregnancies. 
4. Train others on how to use the FC2

Space is limited, please RSVP by clicking here.